대한임상검사과학회지 (Korean Journal of Clinical Laboratory Science)

  • 제51권2호
  • /
  • Pages.221-234
  • /
  • 2019
  • /
  • 1738-3544(pISSN)
  • /
  • 2288-1662(eISSN)
대한임상검사과학회 (Korean Society for Clinical Laboratory Science)
권호 표지
DOI QR코드

DOI QR Code

Hinokitiol에 의해 유도된 Autophagy 및 Apoptosis에 의한 대체 항암요법 연구

Can Hinokitiol Kill Cancer Cells? Alternative Therapeutic Anticancer Agent via Autophagy and Apoptosis

  • 이태복 (서울대학교병원 의학연구혁신센터 공초점현미경실) ;
  • 전진현 (을지대학교 대학원 BK21플러스 시니어헬스케어학과)
  • Lee, Tae Bok (Confocal Core Facility, Center for Medical Innovation, Seoul National University Hospital) ;
  • Jun, Jin Hyun (Department of Senior Healthcare, BK21 Plus Program, Graduate School of Eulji University)
  • 투고 : 2019.05.10
  • 심사 : 2019.05.29
  • 발행 : 2019.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

암은 유전적, 대사질환적 그리고 감염성 질환 등에 의해 유발되는 생명을 위협하는 심각한 질환으로서, 세포의 성장이 정상적으로 통제되지 않으며, 공격적인 형태로 주변의 조직이나 장기로 침범하는 경향을 보이는 생명을 심각하게 위협하는 질병이다. 지난 수십 년 간, 인류의 건강을 위협하는 암을 정복하기 위한 지속적인 노력이 있었고, 암 신생 기전 및 항암제 연구가 항암제 내성에 대한 연구와 함께 다양한 연구주제로 다루어져 왔다. Hinokitiol (${\beta}$-thujaplicin)은 측백나무과 편백속에 속하는 나무에서 분비되는 terpenoid 물질로서, 항염증작용, 항균작용 및 몇몇 암세포 주에서 autophagy를 통한 항암효과가 있는 것으로 잘 알려져 있다. 본 연구에서는, hinokitiol이 세포 영양상태의 변화유무에 관계없이, transcription factor EB (TFEB)의 핵으로의 이동을 촉진한다는 것을 확인하였다. TFEB의 핵으로의 이동은 autophagy 및 lysosome관련 유전자의 발현을 촉진시키고, 세포질 내에 증가된 autosome과 lysosomal puncta의 관찰을 가능하게 하였다. Hinokitiol를 HCC827세포에 처리한 경우에서, 세포 내 autophagy의 증가와 더불어, mitochondria의 hyper-fragmentation과 mitochondria의 authophagic degradation (mitophagy)가 함께 증가되는 것이 관찰되었다. Hinokitiol은 자궁경부암 세포주인 HeLa세포와 비소세포 폐암 세포주인 HCC827에서 암세포 특이 독성을 나타내었다. 더욱이, TFEB 과발현을 통해 autophagy를 인위적으로 증가시킨 HeLa 세포에서 hinokitiol에 대한 세포독성은 더욱 강화된 것으로 나타났다. 이러한 결과들을 통해, hinokitiol은 TFEB의 핵으로의 이동을 촉발시키는 강력한 autophagy inducer임을 확인할 수 있었다. 본 연구에서 처음으로 확인된 hinokitiol에 의한 TFEB의 활성화 및 비소세포성 암세포에서 항암효과의 상승작용은 다양한 항암제 저항성 세포들에 대한 새로운 치료법 및 대체요법 개발과 관련된 의미 있는 결과로 향후, 분자수준의 작용기작에 대한 추가적인 연구가 수행되어야 할 것으로 사료된다.

Cancer is genetically, metabolically and infectiously induced life threatening disorder showing aggressive growing pattern with invasive tendency. In order to prevent this global menace from jeopardizing human life, enormous studies on carcinogenesis and treatment for chemotherapy resistance have been intensively researched. Hinokitiol (${\beta}$-thujaplicin) extracted from heart wood of cupressaceous is a well-known bioactive compound demonstrating anti-inflammation, anti-bacteria and anti-cancer effects on several cancer types via apoptosis and autophagy. This study proposed that hinokitiol activates transcription factor EB (TFEB) nuclear translocation for autophagy and lysosomal biogenesis regardless of nutrient condition in cancer cells. Mitophagy and ${\beta}$-catenin translocation into the nucleus under treatment of hinokitiol on non-small cell lung cancer (NSCLC) cells and HeLa cells were investigated. Hinokitiol exerted cytotoxicity on HeLa and HCC827 cells; moreover, artificially induced autophagy by overexpression of TFEB granted imperfect sustainability onto HeLa cells. Taken together, hinokitiol is the prominent autophagy inducer and activator of TFEB nuclear translocation. Alternative cancer therapy via autophagy is pros and cons since the autophagy in cancer cells is related to prevention and survival mechanism depending on nutrition. To avoid paradox of autophagy in cancer therapy, fine-tuned regulation and application of hinokitiol in due course for successful suppressing cancer cells are recommended.

키워드

참고문헌

  1. Wang WK, Lin ST, Chang WW, Liu LW, Li TY, Kuo CY, et al. Hinokitiol induces autophagy in murine breast and colorectal cancer cells. Environ Toxicol. 2016;31:77-84. https://doi.org/10.1002/tox.22023.
  2. Saniewski M, Horbowicz M, Kanlayanarat S. The biological activities of troponoids and their use in agriculture a review. J Hortic Res. 2014;22:5-19. https://doi.org/10.2478/johr-2014- 0001.
  3. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221:3-12. https://doi.org/10.1002/path.2697.
  4. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728-741. https://doi.org/10.1016/j.cell.2011.10.026.
  5. Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861-2873. https://doi.org/10.1101/gad.1599207
  6. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hishoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672-676. https://doi.org/10.1038/45257
  7. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891-2906. https://doi.org/10.1038/sj.onc.1207521
  8. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332:1429-1433. https://doi.org/10.1126/science.1204592.
  9. Martini-Stoica H, Xu Y, Ballabio A, Zheng H. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016;39:221-234. https://doi.org/10.1016/j.tins.2016.02.0002.
  10. Zhang J, Wang J, Wu J, Lu Y, Jiang J, Wang L, et al. Curcumin targets the TFEB-lysosome pathway for induction of autophagy. Oncotarget. 2016;75659-75671. https://doi.org/10.18632/oncotarget.12318.
  11. Song JX, Sun YR, Peluso I, Zeng Y, Yu X, Lu JH, et al. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 2016;12: 1372-1389. https://doi.org/10.1080/15548627.2016.1179404.
  12. Jayakumar T, Liu CH, Wu GY, Lee TY, Manubolu M, Hsieh CY, at al. Hinokitiol inhibits migration of A549 lung cancer cells via suppression of MMPs and induction of antioxidant enzymes and apoptosis. Int J Mol Sci. 2018;19:E939. https://doi.org/10.3390/ijms19040939.
  13. Ouyang WC, Liao YW, Chen PN, Lu KH, Yu CC, Hsieh PL. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation. Cancer Chemother Pharmacol. 2017;80:411-419. https://doi.org/10.1007/s00280- 017-3381-y.
  14. Huang CH, Jayakumar T, Chang CC, Fong TH, Lu SH, Thomas PA, et al. Hinokitiol exerts anticancer activity through downregulation of MMPs 9/2 and enhancement of catalase and SOD enzymes: in vivo augmentation of lung histoarchitecture. Molecules. 2015;20:17720-17734. https://doi.org/10.3390/molecules201017720.
  15. Li LH, Wu P, Lee JY, Li PR, Hsieh WY, Ho CC, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS One. 2014;9:E104203. https://doi.org/10.1371/journal.pone.0104203.
  16. Ouyang L, Luo Y, Tian M, Zhang SY, Lu R, Wang JH, et al. Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif. 2014;47:506-515. https://doi.org/10.1111/cpr.12143.
  17. Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129:2475-2481. https://doi.org/10.1242/jcs.146365.
  18. Tsao YT, Huang YF, Kuo CY, Lin YC, Chiang WC, Wang WK, et al. Hinokitiol inhibits melanogenesis via AKT/mTOR signaling in B16F10 mouse melanoma cells. Int J Mol Sci. 2016;17:248. https://doi.org/10.3390/ijms17020248.
  19. Lee JH, Jeong JK, Park SY. AMPK activation mediated by hinokitiol inhibits adipogenic differentiation of mesenchymal stem cells through autophagy flux. Int J Endocrinol. 2018;2018: E2014192. https://doi.org/10.1155/2018/2014192.
  20. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:E12. https://doi.org/10.1186/1476-4598-10-12.
  21. Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee CW, Chan FK, et al. The autophagic paradox in cancer therapy. Oncogene. 2012; 31:939-953. https://doi.org/10.1038/onc.2011.295.
  22. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891-2906. https://doi.org/10.1038/sj.onc.1207521
  23. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333:1109-1112. https://doi.org/10.1126/science.1201940.
  24. Gomes LC, Di Benedetto G, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 2011;13:589-598. https://doi.org/10.1038/ncb2220.
  25. Tagaya M, Arasaki K. Regulation of mitochondrial dynamics and autophagy by the mitochondria-associated membrane. Adv Exp Med Biol. 2017;997:33-47. https://doi.org/10.1007/978-981-10-4567-7_3.
  26. Palikaras K, Lionaki E, Tavernarakis N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol. 2018;20:1013-1022. https://doi.org/10.1038/s41556-018-0176-2.
  27. Gkikas I, Palikaras K, Tavernarakis N. The role of mitophagy in innate immunity. Front Immunol. 2018;9:E1283. https://doi.org/10.3389/fimmu.2018.01283.
  28. Wilfinger N, Austin S, Scheiber-Mojdekhar B, Berger W, Reipert S, Praschberger M, at al. Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy. Oncotarget. 2016;7:1242-1261. https://doi.org/10.18632/oncotarget.6233.
  29. Lipinski MM, Zheng B, Lu T, Yan ZY, Py BF, Ng A, et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci USA. 2010;107:14164-14169. https://doi.org/10.1073/pnas.1009485107.
  30. Madeo F, Tavernarakis N, Kroemer G. Can autophagy promote longevity? Nat Cell Biol. 2010;12:842-846. https://doi.org/10.1038/ncb0910-842.
  31. Kim W, Kim M, Jho EH. Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem J. 2013;450:9-21. https://doi.org/10.1042/BJ20121284.
  32. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192-1205. https://doi.org/10.1016/j.cell.2012.05.012.
  33. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26. https://doi.org/10.1016/j.devcel.2009.06.016.
  34. Yoshida T, Sopko NA, Kates M, Liu X, Joice G, McConkey DJ, et al. Three dimensional organoid culture reveals involvement of Wnt b catenin pathway in proliferation of bladder cancer cells. Oncotarget. 2018;9:11060-11070. https://doi.org/10.18632/oncotarget.24308.
  35. Rayan A, Raiyn J, Falah M. Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity. Plos One. 2017;12:E0187925. https://doi.org/10.1371/journal.pone.0187925.
  36. Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol. 2014;85:830-838. https://doi.org/10.1124/mol.114.091850.
  37. Lee TB, Seo EJ, Lee JY, Jun JH. Synergistic anticancer effects of curcumin and hinokitiol on gefitinib resistant non-small cell lung cancer cells. Nat Prod Commun. 2018;13:1667-1671. https://doi.org/10.1177/1934578X1801301223.
  38. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012; 45:487-498. https://doi.org/10.1111/j.1365-2184.2012.00845.x.
  39. Gao C, Cao WP, Bao L, Zuo W, Xie G, Cai T, et al. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol. 2010;12:781-790. https://doi.org/10.1038/ncb2082.
  40. Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461-1473. https://doi.org/10.1038/onc.2016.304.

피인용 문헌

  1. A Lab-Made Wound Maker for Analysis of Cell Migration in a 96-Well Plate vol.52, pp.1, 2019, https://doi.org/10.15324/kjcls.2020.52.1.53
  2. Transcription factor EB agonists from natural products for treating human diseases with impaired autophagy-lysosome pathway vol.15, 2019, https://doi.org/10.1186/s13020-020-00402-1
  3. New Broth Macrodilution Volatilization Method for Antibacterial Susceptibility Testing of Volatile Agents and Evaluation of Their Toxicity Using Modified MTT Assay In Vitro vol.26, pp.14, 2019, https://doi.org/10.3390/molecules26144179
  4. Health Benefits and Pharmacological Properties of Hinokitiol vol.9, pp.9, 2019, https://doi.org/10.3390/pr9091680